Empagliflozin is used for: Empagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Recorded in the NepalDoc medicine catalog for Empagliflozin.
JARDIANCE is indicated: to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure. to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease.
From the U.S. FDA-approved label for Empagliflozin. Full label: DailyMed.
JARDIANCE is indicated: to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure. to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease. as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
From the U.S. FDA-approved label for Empagliflozin. Full label: DailyMed.
Assess volume status and correct volume depletion before initiating Recommended dose is 10 mg once daily in the morning, taken with or without food For additional glycemic control, dose may be increased to 25 mg in patients tolerating JARDIANCE 2.1 Prior to Initiation of JARDIANCE Assess renal function before initiating JARDIANCE and as clinically indicated. In patients with volume depletion, correct this condition before initiating JARDIANCE. 2.2 Recommended Dosage The recommended dose of JARDIANCE is 10 mg once daily in the morning, taken with or without food.
Directions from the U.S. FDA-approved label for Empagliflozin — your doctor or pharmacist may advise differently.
Hypersensitivity to empagliflozin or any of the excipients in JARDIANCE, reactions such as angioedema have occurred. Patients on dialysis. Hypersensitivity to empagliflozin or any of the excipients in JARDIANCE Patients on dialysis
Excerpt from the U.S. FDA-approved label for Empagliflozin. Talk to a pharmacist or doctor before use.
Ketoacidosis: Assess patients who present with signs and symptoms of metabolic acidosis for ketoacidosis, regardless of blood glucose level. If suspected, discontinue JARDIANCE, evaluate and treat promptly. Before initiating JARDIANCE, consider risk factors for ketoacidosis. Patients on JARDIANCE may require monitoring and temporary discontinuation of therapy in clinical situations known to predispose to ketoacidosis. Volume Depletion: Before initiating JARDIANCE, assess volume status and renal function in patients with impaired renal function, elderly patients, or patients on loop diuretics.
Warnings and precautions excerpt from the U.S. FDA-approved label for Empagliflozin — not a complete list. Talk to a pharmacist or doctor before use.
The following important adverse reactions are described below and elsewhere in the labeling: Ketoacidosis Volume Depletion Urosepsis and Pyelonephritis Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues Necrotizing Fasciitis of the Perineum (Fournier's Gangrene) Genital Mycotic Infections Hypersensitivity Reactions Most common adverse reactions (5% or greater incidence) were urinary tract infections and…
Excerpt from the U.S. FDA-approved label for Empagliflozin — not a complete list. Talk to a pharmacist or doctor about side effects.
7 brands · 4 makers in the NepalDoc catalog — see the full Empagliflozin guide →
What is Glifaz?
Glifaz 25mg Tablet is a Empagliflozin medicine made by Magnus Pharma Pvt. Ltd. It comes as 25mg Tablet.
What is Glifaz used for?
Empagliflozin is used for Empagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
What is the generic name of Glifaz?
The generic name of Glifaz is Empagliflozin.
Which brands of Empagliflozin are available in Nepal?
7 brands of Empagliflozin are listed in the NepalDoc catalog, from 4 makers — including Empaz 10mg Tablet, Glifaz 5mg Tablet, Glifaz 10mg Tablet, Glucoemp 10/25mg Tablet, Jardiance 10mg Tablet, Jardiance 25mg Tablet.
What are the side effects of Empagliflozin?
The following important adverse reactions are described below and elsewhere in the labeling: Ketoacidosis Volume Depletion Urosepsis and Pyelonephritis Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues Necrotizing Fasciitis of the Perineum (Fournier's Gangrene) Genital Mycotic Infections Hypersensitivity Reactions Most common adverse reactions (5% or greater incidence) were urinary tract infections and…
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
